Article Abstract

Robotic pancreaticoduodenectomy: a safe minimally invasive option

Abstract

Pancreatic cancer is the 4th leading cause of death in the United States. Over 50,000 patients will be diagnosed with pancreatic cancer in 2019 (1) but only a small percentage of these patients will be operable candidates. This is due to locally advanced or metastatic cancer at time of diagnosis.